Senores Pharmaceuticals
SENORES · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 30, 2024

Stock Price vs Company Growth
1d
1.3%
1w
6.0%
1m
0.9%
3m
7.6%
6m
45.2%
all
38.8%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 774 1.3%
662
832
Company Overview

Sales
517 Cr
Growth: 33.2%
Profit after Tax
87.1 Cr
Growth: 28.9%
Small Cap
3,565 Cr
P/E: 38.9x
Industry P/E: 33.3x
Fundamentals

Sales (Cr) ₹ 517
Growth 33.2%
EBITDA 24.9%
P/S 6.9x
Dividend 0.0%
P/E 38.9x
Book Value ₹ 182
PEG Ratio 1.2x
ROE 13.0%
P/B 4.3x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

Senores Pharmaceuticals Limited was originally incorporated as ‘Senores Pharmaceuticals Private Limited’ under the Companies Act, 2013 through certificate of incorporation dated December 26, 2017, issued by the Registrar of Companies, Central Registration Centre.
Investors (8)
Followers (1)